Kodiak Sciences completes enrollment in Phase 3 PEAK trial cohort

August 6, 2026 7:00 AM

Kodiak Sciences Inc. (Nasdaq: KOD) announced it has completed enrollment of the first 300-patient cohort in its Phase 3 PEAK ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found